Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
European Journal of Preventive Cardiology|February 24, 2021
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registryJuan Caro-Codón, Teresa López-Fernández, Carlos Álvarez-Ortega, et al.
Nature Medicine|April 26, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profilesPaloma Cejas, Lewyn Li, Nicholas K O'Neill, et al.
Journal of Clinical Medicine|April 30, 2021
Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for CancerJaime Feliu, Alvaro Pinto, Laura Basterretxea, et al.
European Heart Journal|February 5, 2020
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registryJosé López-Sendón, Carlos Álvarez-Ortega, Pilar Zamora Auñon, et al.
Molecular & Cellular Proteomics : MCP|February 29, 2020
Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular ClassificationLucía Trilla-Fuertes, Ismael Ghanem, Angelo Gámez-Pozo, et al.
Cell Reports. Medicine|October 8, 2025
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1Jean-Luc Van Laethem, Karen Geboes, Ivan Borbath, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2012
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic targetEnrique Casado, Victor Moreno Garcia, Jose Javier Sánchez, et al.
Oncotarget|March 10, 2015
ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patientsTeodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
Translational Oncology|May 19, 2020
Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell CarcinomaLucía Trilla-Fuertes, Ismael Ghanem, Joan Maurel, et al.
Cancer Medicine|June 19, 2026
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal TimeXabier Garcia-Albeniz, Julia Vila-Guilera, Manuel Zamparini, et al.
Pageof 13